Literature DB >> 9003198

Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2.

Y J Fei1, W Liu, P D Prasad, R Kekuda, T G Oblak, V Ganapathy, F H Leibach.   

Abstract

Histidyl residues are known to be essential for the catalytic function of the H(+)-coupled peptide transporters expressed in the intestine and the kidney, most likely participating in the binding and translocation of H+. Three histidyl residues are conserved among the intestinal and renal peptide transporters (PEPT1 and PEPT2, respectively) from different animal species. In hPEPT1, these residues are His-57, His-121, and His-260. The corresponding residues in hPEPT2 are His-87, His-142, and His-278. We have individually mutated each of these histidyl residues in hPEPT1 and in hPEPT2 and compared the catalytic function of the mutants with that of their respective wild type transporters by expressing the transporters in Xenopus laevis oocytes and also in HeLa cells. His-57 in hPEPT1 and His-87 in hPEPT2 were found to be absolutely essential for catalytic activity because the corresponding mutants had no detectable peptide transport activity. His-121 in hPEPT1 is not essential since mutation of this residue did not impair transport function. His-142 in hPEPT2 was found to play a significant role in the maintenance of transport function but was not found to be obligatory because the mutant had appreciable transport activity. The obligatory histidyl residue (His-57 in hPEPT1 and His-87 in hPEPT2) is located in an almost identical topological position in both transporters, near the extracellular surface of the second putative transmembrane domain. The second conserved histidyl residue is located in the fourth putative transmembrane domain in hPEPT1 as well as in hPEPT2. The third conserved histidyl residue is present in the cytoplasmic loop between the transmembrane domains 6 and 7 and is unlikely to play any significant role in the binding and translocation of H+ and this was supported by the findings that mutation of this histidyl residue in hPEPT1 did not interfere with transport function. The loss of transport function of hPEPT1 and hPEPT2, when His-57 in hPEPT1 and His-87 in hPEPT2 were mutated, was not due to alterations in protein expression because the expression levels of these mutants were similar to those of the respective wild type transporters in HeLa cells as assessed by immunoblot analysis. Confocal analysis of immunofluorescence in X. laevis oocytes expressing the wild type and the three histidine mutants of hPEPT1 showed that the transporter protein is expressed exclusively in the plasma membrane and that the level of expression is comparable among the wild type and the three mutants. These site-directed mutagenesis studies clearly show that His-57 in hPEPT1 and His-87 in hPEPT2 are the most critical histidyl residues necessary for the catalytic function of these transporters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003198     DOI: 10.1021/bi962058p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition.

Authors:  T Terada; H Saito; K Sawada; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

2.  Evidence for allosteric regulation of pH-sensitive System A (SNAT2) and System N (SNAT5) amino acid transporter activity involving a conserved histidine residue.

Authors:  Fiona E Baird; Jorge J Pinilla-Tenas; William L J Ogilvie; Vadival Ganapathy; Harinder S Hundal; Peter M Taylor
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

Review 3.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Molecular mechanisms of electrogenic sodium bicarbonate cotransport: structural and equilibrium thermodynamic considerations.

Authors:  I Kurtz; D Petrasek; S Tatishchev
Journal:  J Membr Biol       Date:  2004-01-15       Impact factor: 1.843

Review 5.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

6.  Residues R282 and D341 act as electrostatic gates in the proton-dependent oligopeptide transporter PepT1.

Authors:  Elena Bossi; Maria Daniela Renna; Rachele Sangaletti; Francesca D'Antoni; Francesca Cherubino; Gabor Kottra; Antonio Peres
Journal:  J Physiol       Date:  2010-11-29       Impact factor: 5.182

7.  Functional and structural determinants of reverse operation in the pH-dependent oligopeptide transporter PepT1.

Authors:  Maria Daniela Renna; Ayodele Stephen Oyadeyi; Elena Bossi; Gabor Kottra; Antonio Peres
Journal:  Cell Mol Life Sci       Date:  2010-12-23       Impact factor: 9.261

8.  Redesigning channel-forming peptides: amino acid substitutions that enhance rates of supramolecular self-assembly and raise ion transport activity.

Authors:  Lalida P Shank; James R Broughman; Wade Takeguchi; Gabriel Cook; Ashley S Robbins; Lindsey Hahn; Gary Radke; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

9.  Development and utility of anti-PepT1 anti-peptide polyclonal antibodies.

Authors:  S K Basu; J Shen; K J Elbert; C T Okamoto; V H Lee; H von Grafenstein
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

Review 10.  Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.

Authors:  Thomas Gerloff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.